AnaptysBio raises $208M following Phase IIa asthma readout

By Allison Johnson | Sep 26, 2018 | 5:32 PM GMT

AnaptysBio Inc. (NASDAQ:ANAB) raised $207.8 million late Tuesday through the sale of 2.2 million shares at $94.46 in a follow-on underwritten by Credit Suisse, J.P.